drugset / Trial / NCT00432341

Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia

NCT00432341

Phase 4 Terminated 54 enrolled Allergan
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare two types of botulinum toxin type A to treat the involuntary muscle contractions in the neck

Timeline

Start
2007-06
Primary completion
2009-03
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 200 iu
Comparator Botulinum toxin type A Protein / enzyme biologic 500 iu

Indications